Abstracts

Relationship Between Efavirenz Trough & CYP2B6 Genotypes with Rifampin-Based TB Therapy in STRIDE

Background: Rifampin(RIF) induces cytochrome P450 (CYP) isoforms, which can lower plasma EFV exposure. However, in STRIDE, RIF-containing tuberculosis therapy was associated with increased EFV Cmin. As CYP2B6 polymorphisms predict EFV exposure, we conducted a nested pharmacogenomics study to evaluate EFV Cmin by CYP2B metabolizer status in STRIDE participants. Methodology: EFV Cmin was measured by HPLC(LLQ…

Pharmacokinetics of Faldaprevir and Antiretrovirals in Patients with HIV/HCV Coinfection

Background: Faldaprevir (FDV) is a potent, once-daily HCV NS3/4A protease inhibitor being developed for the treatment of HCV genotype 1 infection in mono-infected patients and HIV co-infected patients. In studies in healthy volunteers, FDV increased raltegravir (RAL) exposure by about 2.5-fold and had no substantial effect on the pharmacokinetics (PK) of darunavir/ritonavir (DRV/r), efavirenz (EFV),…

Relative genetic contribution to the pharmacokinetics of commonly prescribed antiretrovirals

Background: Variability in antiretroviral pharmacokinetics is influenced by numerous factors affecting absorption, distribution, metabolism and elimination. Recently, a relative genetic contribution (rGC) of 0.904 (0.64 – 0.97) was reported for nevirapine (NVP) AUC0-6h (Micheli et al, Pharmacogenet Genomics, 2013). The aim of this study was to assess the rGC of a panel of antiretroviral drugs…

Leveraging Genomics in HIV Treatment Decisions

Background: Patient genotype influences outcome of HIV infection and treatment. In a pilot project, we test implementation (operational, semantic, procedures for delivery), doctor’s perception and predictive power of a custom genotyping array that synthesizes current knowledge on genetic variants that contribute to clinical phenotypes in HIV. Methodology: The array includes 4,146 SNPs that capture known…

HIV Surveillance and Parallel Virome Analysis Using Unbiased Next-Generation Sequencing

Background: Next-generation sequencing (NGS) has the potential to revolutionize strategies for HIV surveillance, genome characterization, and minor variant analysis. Moreover, application of this technology in an unbiased manner offers the promise of simultaneous detection and characterization of viral co-infections. In this study, we examined the utility of high-throughput sequence analysis for characterization of HIV and…

Higher CD4 at ART Initiation Predicts Greater Long Term Likelihood of CD4 Normalization

Background: Higher plasma CD4 cell counts per mm3 at ART initiation (AI-CD4) improve long-term CD4 responses and survival. Recent data suggest attaining CD4 > 750 is a clinically significant threshold for AIDS-related illness reduction and immune “normalization”. We evaluated the effect of AI-CD4 on chances of achieving CD4 > 750 and mortality risk. Methodology: Among…